IVI Bilbao
13
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
46.2%
6 terminated/withdrawn out of 13 trials
50.0%
-36.5% vs industry average
23%
3 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Self Monitoring Device Fortrasvaginal Ultrasound in Reproduction
Role: lead
Influence of PRGF (Plasma Rich in Growth Factors) Puncture in Ovaries With Low Follicular Reservetechniques
Role: lead
Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo Transfer
Role: collaborator
Microbiome and Endometrial Receptivity in Obese Infertile Women
Role: collaborator
Embryo Implantation After Induced Endometrial Injury
Role: collaborator
Effect of Plasma Rich in Growth Factors on Semen Quality
Role: lead
Influence Instillation Plasma Rich in Growth Factors in Endometrial Cavity Endometrial Development in Assisted Reproduction.
Role: lead
Analysis of Lipid Profiles in Samples Sperm and Seminal Plasma Under Artificial Insemination
Role: lead
Influence of Physical Exercise on Semen Quality
Role: lead
Influence of the Antioxidant Treatment in the Oxidant-reduction Potential in Seminal Plasma in Men Whose Partners Will Undergo Through an Egg Donation Cycle
Role: lead
Role of Intrauterine Insemination in Patients With Endometriosis I-II
Role: lead
Determining the Genetic Profile in Semen Donors With Pregnancy, Donor Versus no Pregnancy Obtained in TRA
Role: lead
Biosimilar Versus Urinary Gonadotropins
Role: collaborator
All 13 trials loaded